Skip to main content
Equibles

Triumph Capital Management

Position in COYA — Coya Therapeutics, Inc.

CIK 1730765 DENVER, CO
Back to COYA Full portfolio

Position in COYA

as of Jun 30, 2026 · filed Jul 21, 2026
Position Value
$292
+$95 QoQ
Shares Held
50
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 54 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in COYA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Triumph Capital Management holds $2,971,996 across 21 Biotechnology names. COYA ranks #19 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELDN
Eledon Pharmaceuticals, Inc.
 303,443 $1,195,565
2 INCY
Incyte Corp
 6,801 $770,961
3 JAZZ
Jazz Pharmaceuticals plc
 2,597 $625,799
4 REGN
Regeneron Pharmaceuticals, Inc.
 414 $258,145
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 112 $55,633
6 ARQT
Arcutis Biotherapeutics, Inc.
 900 $23,598
7 RIGL
Rigel Pharmaceuticals Inc
 200 $7,824
8 MRNA
Moderna, Inc.
 100 $7,003

All Filings in COYA

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $292 50
2026-03-31 $197 50
2025-12-31 $290 50